Research Explorer

Project

Proteomics-derived epitopes for dramatically improved anticancer and antibacterial vaccine development
Code
01G03321
Duration
01 January 2021 → 31 December 2024
Funding
Regional and community funding: Special Research Fund
Promotor-spokesperson
Research disciplines
  • Natural sciences
    • Structural bioinformatics and computational proteomics
    • Proteomics
  • Medical and health sciences
    • Applied immunology
    • Vaccinology
    • Cancer therapy
Keywords
Proteomics bio-informatics vaccines lung cancer bacterial infection tuberculosis
 
Project description
 

This project seeks to dramatically improve the development of anticancer and antibacterial vaccines by removing the two most important thresholds to development: difficulties in identifying suitable epitopes, and the lack of effective vaccine formulations. We will moreover demonstrate our approach on two highly relevant cases: tuberculosis and lung cancer.